Biomarker discovery is one of the newly emerging innovations in the diagnosis and
treatment of cancer and many other diseases. Many research groups and large …

Over a last decade, intense interest has been focused on biomarker discovery and their
clinical uses. This interest is accelerated by the completion of human genome project and …

Lung cancer is the most common cause of cancer death in both men and women in Western
countries, with a 5‐year survival rate of 15%, which is among the lowest of all cancers. The …

Although the incidence and mortality of lung cancer have decreased significantly in the past
decade, it is still one of the leading causes of death, which greatly impairs people's life and …

In the last decade, proteomic analysis has become an integral tool for investigation of tumor
biology, complementing the genetic analysis. The idea of proteomics is to characterize …

The overall survival of lung cancer patients is disappointingly low. This is due to several
factors, including the lack of an effective screening strategy to detect tumors at a potentially …

Proteomic techniques are currently used to understand the biology of different human
diseases, including studies of the cell signaling pathways implicated in cancer progression …

Lung cancer is the leading cause of cancer death in men and women in Western nations,
and is among the deadliest cancers with a 5‐year survival rate of 15%. The high mortality …

Introduction: Lung cancer and related diseases have been one of the most common causes
of deaths worldwide. Genomic-based biomarkers may hardly reflect the underlying dynamic …

Lung cancer is the most frequently occurring cancer in the world and continually leads in
mortality among cancers. The overall 5-year survival rate for lung cancer has risen only …